Formulation of a novel anti-human oral squamous cell carcinoma supplement by gold nanoparticles-Kaolin nanocomposite

References

• Borm PJ, Robbins D, Haubold S, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 2006;3(1):11.
   Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133–149.
   Google Scholar
• Mao B-H, Tsai J-C, Chen C-W, et al. Mechanisms of silver nanoparticle-induced toxicity and important role of autophagy. Nanotoxicology. 2016;10(8):1021–1040.
   Google Scholar
• You C, Han C, Wang X, et al. The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep. 2012;39(9):9193–9201.
   Google Scholar
• Trojer MA, Li Y, Wallin M, et al. Charged microcapsules for controlled release of hydrophobic actives part II: surface modification by LbL adsorption and lipid bilayer formation on properly anchored dispersant layers. J Colloid Interface Sci. 2013;409:8–17.
   Google Scholar
• Liu D, Chen L, Jiang S, et al. Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology. J Liposome Res. 2014;24(1):17–26.
   Google Scholar
• Tong AM, Lu WY, Xu JH, et al. Bioorg. Med. Chem. Lett. 2004;14:2095–2097.
   Google Scholar
• T, Baran I, Sargin M, Kaya, et al. Clean Technol Environ Policy. 2021;23:1797–1806.
   Google Scholar
• Wang X, Hu P, Xue F, et al. Cellulose-supported N-heterocyclic carbene-palladium catalyst: synthesis and its applications in the suzuki cross-coupling reaction. Carbohydr Polym. 2014;114:476–483.
   Google Scholar
• Veisi H, Sedrpoushan A, Faraji AR, et al. RSC Adv. 2018;810:69–77.
   Google Scholar
• Veisi H, Joshani Z, Karmakar B, et al. Ultrasound assisted synthesis of Pd NPs decorated chitosan-starch functionalized Fe3O4 nanocomposite catalyst towards Suzuki-Miyaura coupling and reduction of 4-nitrophenol. Int J Biol Macromol. 2021;172:104–113.
   Google Scholar
• Budarin VL, Clark JH, Luque R, et al. Palladium nanoparticles on polysaccharide-derived mesoporous materials and their catalytic performance in C–C coupling reactions. Green Chem. 2008;10(4):382–387.
   Google Scholar
• Shaabani A, Rahmati A, Badri Z. Sulfonated cellulose and starch: New biodegradable and renewable solid acid catalysts for efficient synthesis of quinolines. Catal Commun. 2008;9(1):13–16.
   Google Scholar
• Zhou CH. An overview on strategies towards clay-based designer catalysts for green and sustainable catalysis. Appl Clay Sci. 2011;53(2):87–e96.
   Google Scholar
• Lin Y, Li L, Hu L, et al. Multifunctional poly(dopamine)-assisted synthesis of silver nano particles/carbon nanotubes nanocomposite: toward electrochemical sensing of hydrogen peroxide with enhanced sensitivity. Sensor Actuat B-Chem. 2014;202:527–535.
   Google Scholar
• Ramprakash Upadhyay P, Srivastava V. Clays: an encouraging catalytic support. CCAT. 2016;5(3):162–181.
   Google Scholar
• He K, Zeng Z, Chen A, et al. Advancement of Ag-graphene based nanocomposites: an overview of synthesis and its applications. Small. 2018;14(32):1800871.
   Google Scholar
• Ma H, Wang B, Wang Y. Application of molybdenum and phosphate modified kaolin in electrochemical treatment of paper mill wastewater. J Hazard Mater. 2007;145(3):417–423.
   Google Scholar
• Kurtan U, Amir M, Yıldız A, et al. Synthesis of magnetically recyclable MnFe 2 O 4 @SiO 2 @Ag nanocatalyst: its high catalytic performances for azo dyes and nitro compounds reduction. Appl Surf Sci. 2016;376:16–25.
   Google Scholar
• Ai L, Zeng C, Wang Q. One-step solvothermal synthesis of Ag-Fe3O4 composite as a magnetically recyclable catalyst for reduction of rhodamine B. Catal Commun. 2011;14(1):68–e73.
   Google Scholar
• Lu Y, Wan X, Li L, et al. Synthesis of a reusable composite of graphene and silver nanoparticles for catalytic reduction of 4-nitrophenol and performance as anti-colorectal carcinoma. J Mater Res Technol. 2021;12:1832–1843.
   Google Scholar
• Yang F, Jin C, Jiang Y, et al. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer Treat Rev. 2011;37(8):633–642.
   Google Scholar
• Xinli DHZS. Applications of nanocarriers with tumor molecular targeted in chemotherapy. Chemistry. 2012; 75(7):621–627.
   Google Scholar
• Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer. 2002;2(10):750–763.
   Google Scholar
• Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Del Rev. 2008;60(15):1615–1626.
   Google Scholar
• Gao J, Wang Z, Liu H, et al. Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation. Drug Discov Ther. 2015;9(3):205–212.
   Google Scholar
• Mohammed MI, Makky AM, Teaima MH, et al. Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study. Drug Deliv. 2016;23(5):1558–1564.
   Google Scholar
• Li YN, G F. Recent progress in doxorubicin nano-drug delivery systems for reserving multidrug resistance. 2014;11(3):177–181.
   Google Scholar
• Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 2007;9(2):E128–E147.
   Google Scholar
• Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine (Lond)). 2013;8(9):1509–1528.
   Google Scholar
• Zhang Y, Huang Y, Li S. Polymeric micelles: nanocarriers for cancer-targeted drug delivery. AAPS PharmSciTech. 2014;15(4):862–871.
   Google Scholar
• Gao Z, Lukyanov AN, Singhal A, et al. Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett. 2002;2(9):979–982.
   Google Scholar
• Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771–782.
   Google Scholar
• Matsumura Y, Hamaguchi T, Ura T, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer. 2004;91(10):1775–1781.
   Google Scholar
• Nie S, Xing Y, Kim GJ, et al. Nanotechnology applications in cancer. Annu Rev Biomed Eng. 2007;9:257–288.
   Google Scholar
• Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: Recent advances and perspectives soc. Chem Soc Rev. 2012;41(6):2256–2282.
   Google Scholar
• Dreaden EC, Alkilany AM, Huang X, et al. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev. 2012;41(7):2740–2779.
   Google Scholar
• Abraham GE, Himmel PBJ. Management of rheumatoid arthritis: rationale for the use of colloidal metallic gold. J Nutr Environ Med. 1997;7:295–305.
   Google Scholar
• Abraham GE. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Nat. 2008;15:132–158.
   Google Scholar
• Tsai CY, Shiau AL, Chen SY. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm. 2007;56:544–554.
   Google Scholar
• Brown CL, Whitehouse MW, Tiekink ERT, et al. Colloidal metallic gold is not bio-inert. Inflammopharmacology. 2008;16(3):133–137.
   Google Scholar
• Paciotti GF, Myer L, Weinreich D, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11(3):169–183.
   Google Scholar
• Paciotti GF, Kingston DGI, Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumortargeted drug delivery vectors. Drug Dev Res. 2006;67(1):47–54.
   Google Scholar
• Park H, Tsutsumi H, Mihara H. Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles . Biomaterials. 2013;34(20):4872–4879.
   Google Scholar
• Dreaden EC, Austin LA, Mackey MA, et al. Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv. 2012;3(4):457–478.
   Google Scholar
• Remant Bahadur KC. Gold nanoparticle-based gene delivery: promises and challenges. Nanotechnol Rev. 2014;3(3):269–280.
   Google Scholar
• Mendes R, Fernandes A, Baptista P. Gold nanoparticle approach to the selective delivery of gene silencing in cancer the case for combined delivery? Genes. 2017;8(3):94.
   Google Scholar
• Huang X, Jain PK, El-Sayed IH, et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008;23(3):217–228.
   Google Scholar
• Cruz LJ, Tacken PJ, Rueda F, et al. Targeting nanoparticles to dendritic cells for immunotherapy. Methods Enzymol. 2012;509:143–163.
   Google Scholar
• Andersson HA, Kim Y-S, O'Neill BE, et al. HSP70 promoterdriven activation of gene expression for immunotherapy using gold nanorods and near infrared light. Vaccines. 2014;2:216–227.
   Google Scholar
• Blagoi Yu P, Galkin VL, Gladchenko GO, et al. Metal complexes of nucleic acids in solutions. Naukova Dumka: Kiev; 1991. p. 272.
   Google Scholar
• Sriram MI, ManiKanth SB, Kalishwaralal K, et al. Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int J Nanomed. 2010;5:753–762.
   Google Scholar
• Martins D, Frungillo L, Anazzetti MC, et al. Antitumoral activity of L-ascorbic acid-poly- D,L-(lactide-co-glycolide) nanoparticles containing violacein. Int J Nanomed. 2010;5:77–85.
   Google Scholar
• Nam J, Won N, Jin H, et al. pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. J Am Chem Soc. 2009;131(38):13639–13645.
   Google Scholar
• Devi JS, Bhimba BV. Anticancer activity of silver nanoparticles synthesized by the seaweed Ulva lactuca in vitro. Sci Rep. 2012;1(4):242.
   Google Scholar
• Holt JG, Krieg RN, Sneath PHA, et al. Bergey’s manual of determinative bacteriology. 9th ed. Baltimore: Williams and Wilkins;1994.
   Google Scholar
• Rajeshkumar S, Malarkodi C, Vanaja M, et al. Anticancer and enhanced antimicrobial activity of biosynthesizd silver nanoparticles against clinical pathogens. J Mol Struct. 2016;1116:165–173.
   Google Scholar